» Articles » PMID: 32323806

Baicalin Alleviates Bleomycin‑induced Pulmonary Fibrosis and Fibroblast Proliferation in Rats Via the PI3K/AKT Signaling Pathway

Overview
Journal Mol Med Rep
Specialty Molecular Biology
Date 2020 Apr 24
PMID 32323806
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Baicalin is an important flavonoid compound THAT is isolated from the Scutellaria baicalensis Georgi Chinese herb and plays a critical role in anti‑oxidative, anti‑inflammatory, anti‑infection and anti‑tumor functions. Although baicalin can suppress the proliferation of tumor cells, the underlying mechanisms of baicalin in bleomycin (BLM)‑induced pulmonary fibrosis remain to be elucidated. Thus, the aim of the present study was to determine the role of baicalin in pulmonary fibrosis and fibroblast proliferation in rats. Hematoxylin and eosin (H&E) and Masson staining were used to measure the morphology of pulmonary fibrosis, ELIASA kits were used to test the ROS and inflammation, and western blotting and TUNEL were performed to study the apoptosis proteins. In vitro, MTT assay, flow cytometry, western blotting and immunofluorescence were performed to investigate the effects of baicalin on proliferation of fibroblasts. The most significantly fibrotic changes were identified in the lungs of model rats at day 28. Baicalin (50 mg/kg) attenuated the degree of pulmonary fibrosis, and the hydroxyproline content of the lung tissues was decreased in the baicalin group, compared with the BLM group. Further investigation revealed that baicalin significantly increased glutathione peroxidase (GSH‑px), total‑superoxide dismutase (T‑SOD) and glutathione (GSH) levels, whilst decreasing that of serum malondialdehyde (MDA). TUNEL‑positive cells were significantly decreased in rats treated with baicalin group, compared with the model group. Furthermore, it was found that BLM promoted fibroblasts viability in a dose‑dependent manner in vivo, which was restricted following treatment with different concentrations of baicalin. Moreover, BLM promoted the expression levels of cyclin A, D and E, proliferating cell nuclear antigen, phosphorylated (p)‑AKT and p‑calcium/calmodulin‑dependent protein kinase type. BLM also promoted the transition of cells from the G0/G1 phase to the G2/M and S phases, and increased the intracellular Ca2+ concentration, which was subsequently suppressed by baicalin. Collectively, the results of the present study suggested that baicalin exerted a suppressive effect on BLM‑induced pulmonary fibrosis and fibroblast proliferation.

Citing Articles

Research advances in polyphenols from Chinese herbal medicine for the prevention and treatment of chronic obstructive pulmonary disease: a review.

Zhang Y, Wang L, Zeng J, Shen W Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40035820 DOI: 10.1007/s00210-025-03945-y.


Modulating NLRP3 Inflammasomes in Idiopathic Pulmonary Fibrosis: A Comprehensive Review on Flavonoid-Based Interventions.

Vithalkar M, Pradhan S, Sandra K, Bharath H, Nayak Y Cell Biochem Biophys. 2025; .

PMID: 39966334 DOI: 10.1007/s12013-025-01696-4.


3,5,6,7,8,3',4'- Heptamethoxyflavonoid inhibits TGF-β1-induced epithelial-mesenchymal transition by regulating oxidative stress and autophagy through MEK/ERK/PI3K/AKT/mTOR signaling pathway.

Wang Y, Ma Z, Peng W, Yu Q, Liang W, Cao L Sci Rep. 2025; 15(1):4567.

PMID: 39915543 PMC: 11802913. DOI: 10.1038/s41598-025-88869-6.


Analysis of gut microbiota-derived metabolites regulating pituitary neuroendocrine tumors through network pharmacology.

Cao M, Huang P, Xu L, Zhang Y Front Pharmacol. 2024; 15:1403864.

PMID: 39295931 PMC: 11408289. DOI: 10.3389/fphar.2024.1403864.


Global research status and trends of interactions between Traditional Chinese medicine and pulmonary fibrosis: A new dawn in treatment.

Wei B, Li H, Wang C, Hu J Heliyon. 2024; 10(14):e34592.

PMID: 39149021 PMC: 11325230. DOI: 10.1016/j.heliyon.2024.e34592.


References
1.
Ji Y, Luo Z, Chen C, Li B, Gong J, Wang Y . BML-111 suppresses TGF-β1-induced lung fibroblast activation in vitro and decreases experimental pulmonary fibrosis in vivo. Int J Mol Med. 2018; 42(6):3083-3092. PMC: 6202103. DOI: 10.3892/ijmm.2018.3914. View

2.
Hsu H, Liu C, Lin J, Hsu T, Hsu J, Su K . Involvement of ER stress, PI3K/AKT activation, and lung fibroblast proliferation in bleomycin-induced pulmonary fibrosis. Sci Rep. 2017; 7(1):14272. PMC: 5660192. DOI: 10.1038/s41598-017-14612-5. View

3.
Yuan J, Li P, Pan H, Li Y, Xu Q, Xu T . miR-542-5p Attenuates Fibroblast Activation by Targeting Integrin α6 in Silica-Induced Pulmonary Fibrosis. Int J Mol Sci. 2018; 19(12). PMC: 6320929. DOI: 10.3390/ijms19123717. View

4.
Inghilleri S, Morbini P, Oggionni T, Barni S, Fenoglio C . In situ assessment of oxidant and nitrogenic stress in bleomycin pulmonary fibrosis. Histochem Cell Biol. 2005; 125(6):661-9. DOI: 10.1007/s00418-005-0116-7. View

5.
Akter T, Silver R, Bogatkevich G . Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease. Curr Rheumatol Rep. 2014; 16(4):411. DOI: 10.1007/s11926-014-0411-1. View